B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis
Katharina Hopp(University of Colorado Denver), Peter C. Harris(Mayo Clinic), Jamie L. Sundsbak(Mayo Clinic), Peter G. Czarnecki(Beth Israel Deaconess Medical Center), Shail Patel(Hypertension Institute), Mark Consugar(Massachusetts Eye and Ear Infirmary), Vicente E. Torres(Mayo Clinic in Arizona), Troy J. Gliem(Mayo Clinic), Priyanka Patel(Hypertension Institute), Christina M. Heyer(Mayo Clinic), Sandro Rossetti(Mayo Clinic), Cynthia J. Hommerding(Mayo Clinic), Susan A. Henke(Genomics (United Kingdom))
Cited by 89
Related Papers
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2015|602
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2014|524
Mutations in GANAB , Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease
|The American Journal of Human Genetics|2016|463
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca <sup>2+</sup> -permeable nonselective cation channel
|Proceedings of the National Academy of Sciences|2000|447
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
|Journal of Clinical Investigation|2012|444